Your browser doesn't support javascript.
loading
Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants.
Mizoue, Tetsuya; Yamamoto, Shohei; Konishi, Maki; Oshiro, Yusuke; Inamura, Natsumi; Nemoto, Takashi; Ozeki, Mitsuru; Horii, Kumi; Okudera, Kaori; Sugiyama, Haruhito; Aoyanagi, Nobuyoshi; Sugiura, Wataru; Ohmagari, Norio.
Afiliação
  • Mizoue T; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, Tokyo 162-8655, Japan. Electronic address: mizoue@hosp.ncgm.go.jp.
  • Yamamoto S; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, Tokyo 162-8655, Japan.
  • Konishi M; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, Tokyo 162-8655, Japan.
  • Oshiro Y; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Inamura N; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Nemoto T; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Ozeki M; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Horii K; Infection Control Office, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
  • Okudera K; Infection Control Office, Kohnodai Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Sugiyama H; Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Aoyanagi N; Kohnodai Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Sugiura W; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
J Infect ; 85(5): 573-607, 2022 11.
Article em En | MEDLINE | ID: mdl-35995310
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas do Nucleocapsídeo / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas do Nucleocapsídeo / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2022 Tipo de documento: Article